These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16059417)

  • 21. Cost-effectiveness of universal influenza vaccination in a pregnant population.
    Roberts S; Hollier LM; Sheffield J; Laibl V; Wendel GD
    Obstet Gynecol; 2006 Jun; 107(6):1323-9. PubMed ID: 16738159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring vaccine safety during an influenza pandemic.
    Iskander J; Haber P; Herrera G
    Yale J Biol Med; 2005 Oct; 78(5):265-75. PubMed ID: 17132333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Public health. Who should get influenza vaccine when not all can?
    Emanuel EJ; Wertheimer A
    Science; 2006 May; 312(5775):854-5. PubMed ID: 16690847
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaccines in development against avian influenza.
    Cox MM
    Minerva Med; 2007 Apr; 98(2):145-53. PubMed ID: 17519856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
    Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
    Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National briefing: science and health--influenza vaccine supply expected to meet demand, CDC recommends influenza vaccinations begin in October.
    J Miss State Med Assoc; 2003 Aug; 44(8):266-7. PubMed ID: 14531231
    [No Abstract]   [Full Text] [Related]  

  • 27. Pandemic influenza: overview of vaccines and antiviral drugs.
    Cox MM
    Yale J Biol Med; 2005 Oct; 78(5):321-8. PubMed ID: 17132338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is PHARMAC's sole-supply tendering policy harming the health of New Zealanders?
    MacKay P
    N Z Med J; 2005 May; 118(1214):U1433. PubMed ID: 15886729
    [No Abstract]   [Full Text] [Related]  

  • 29. Influenza vaccine supply, 2005-2006: did we come up short?
    Bardenheier BH; Strikas R; Kempe A; Stokley S; Ellis J
    BMC Health Serv Res; 2007 May; 7():66. PubMed ID: 17480227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The United States vaccine supply: challenges in preparing for an avian influenza pandemic.
    Straus WL
    Yale J Biol Med; 2005 Oct; 78(5):255-64. PubMed ID: 17132332
    [No Abstract]   [Full Text] [Related]  

  • 31. Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: a prospective cohort study.
    Salleras L; Domínguez A; Pumarola T; Prat A; Marcos MA; Garrido P; Artigas R; Bau A; Brotons J; Bruna X; Català P; Carreras E; Cuadra D; Gatell A; Millet S; Oller J; Raga E
    Vaccine; 2006 Nov; 24(44-46):6638-42. PubMed ID: 16842892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Half-dose influenza vaccine: stretching the supply or wasting it?
    Falsey AR
    Arch Intern Med; 2008 Dec; 168(22):2402-3. PubMed ID: 19064820
    [No Abstract]   [Full Text] [Related]  

  • 33. Production technologies change flu vaccine landscape.
    Sheridan C
    Nat Biotechnol; 2007 Jul; 25(7):701. PubMed ID: 17621280
    [No Abstract]   [Full Text] [Related]  

  • 34. All I want for Christmas is my flu vaccine.
    South DS
    J Miss State Med Assoc; 2005 Dec; 46(12):393-4. PubMed ID: 16450551
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
    Collin N; de Radiguès X;
    Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationing vaccine during an avian influenza pandemic: why it won't be easy.
    Arras JD
    Yale J Biol Med; 2005 Oct; 78(5):287-300. PubMed ID: 17132335
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.
    Arnoux S; Weinberger C; Gessner BD
    Vaccine; 2007 Nov; 25(45):7720-31. PubMed ID: 17920168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine manufacturing: challenges and solutions.
    Ulmer JB; Valley U; Rappuoli R
    Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of a severe influenza vaccine shortage on primary care practice.
    Kempe A; Daley MF; Stokley S; Crane LA; Beaty BL; Barrow J; Babbel C; Dickinson LM; Steiner JF; Berman S
    Am J Prev Med; 2007 Dec; 33(6):486-91. PubMed ID: 18022065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.